健康教育配合利拉鲁肽单药治疗新诊断超重2型糖尿病的临床分析  

Effect of health education with liraglutide treatment for newly diagnosed overweight patients with type 2 diabetes

作　　者：宋颖[1] 魏巍[1] 

机构地区：[1]中国医科大学附属盛京医院第二内分泌内科,沈阳110004

出　　处：《实用药物与临床》2013年第6期499-500,共2页Practical Pharmacy and Clinical Remedies

摘　　要：目的总结健康教育配合利拉鲁肽治疗新诊断超重2型糖尿病患者的临床疗效。方法住院时责任护士对30例超重2型糖尿病患者进行整体评估,结合评估结果对患者施行整体健康教育,配合利拉鲁肽药物治疗,出院后进行延续性护理。治疗12周后,观察治疗前后空腹血糖、餐后2 h血糖、糖化血红蛋白、BMI及有无低血糖等不良事件发生。结果 30例患者治疗12周后,空腹血糖、餐后血糖、糖化血红蛋白、BMI均明显下降,无低血糖事件发生。结论系统的健康教育配合利拉鲁肽是超重2型糖尿病患者早期治疗的理想选择。Objective To summarize the clinical effect of health education with liraglutide treatment for newly diagnosed overweight patients with type 2 diabetes. Methods The patient＇s situation was assessed, and the health edu-cation combined with liraglutide treatment was given to them according to the asessment results by nurses, and the con-tinuity of care was served after discharge. The fasting blood glucose, 2 h postprandial blood glucose, glycosylated hemo- globin, BMI and the adverse reaction （ such as hypoglycemia） were observed before and after treatment. Results After 12 weeks of treatment, the fasting blood, postprandial blood glucose, glycosylated hemoglobin and BMI decrease signifi-cantly, no hypoglycimia was observed. Conclusion The health education with liraglutide treatment is ideal for early selection of treatment for overweight patients with type 2 diabetes mellitus.

关 键 词：利拉鲁肽 2型糖尿病 超重 健康教育 

分 类 号：R587.1[医药卫生—内分泌]